Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116287086B reveals enzymatic water-phase synthesis for tazobactam. Offers cost reduction in pharmaceutical intermediates manufacturing and high-purity output.
Patent CN109553547B reveals a novel vacuum crystallization method for high-purity beta-hydroxyalkylamides, offering significant cost reduction and supply reliability for coating manufacturers.
Patent CN110272839A enables high-purity chiral acid synthesis. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing for global partners.
Patent CN100358914C details a novel one-step acetylation for Deflazacort production, offering significant cost reduction and improved purity for pharmaceutical intermediate manufacturing.
Discover a novel organocatalytic route for Trichostatin A synthesis offering superior yield and stability. Reliable supplier for high-purity pharmaceutical intermediates.
Patent CN101081802B details a green ionic liquid method for exo-THDCPD isomerization, offering high purity and yield for reliable fine chemical intermediate supply chains.
Patent CN104531794B reveals enzymatic route for high-purity chiral intermediate with scalable production capabilities and cost advantages.
Advanced one-step synthesis of 2,2'-dinitrostilbene via patent CN102627565A. Eliminates bromination, ensures high purity for Carbamazepine manufacturing with reduced costs.
Patent CN102757924A details a novel Rhodococcus strain for high-purity (S)-(+)-DMCPA production, offering superior enantioselectivity and scalable manufacturing for cilastatin synthesis.
Patent CN1111677A reveals a thermophilic Bacillus smithii strain for stable nitrile hydration, enabling cost reduction in pharmaceutical intermediate manufacturing without cooling.
Analysis of CN118164991A reveals a palladium-free route for aminopyrimidopyrazole derivatives, offering cost reduction in API intermediate manufacturing and high purity.
Novel ionic liquid-mediated Heck coupling for trans-resveratrol. High yield, green process, cost-effective manufacturing for pharmaceutical intermediates.
Patent CN102603660A details a green one-pot synthesis of 1H-1,2,3-triazoles using porous copper. Offers cost reduction and high purity for pharmaceutical intermediates.
Patent CN102719500A details a continuous immobilized enzyme method for GABA. Offers high purity, green synthesis, and cost reduction for food additive manufacturing.
Patent CN10554191918A reveals high-yield chiral catalyst synthesis. Offers supply chain stability and cost efficiency for asymmetric pharmaceutical manufacturing processes.
Novel two-step synthesis patent reduces waste and improves safety for high-purity herbicide manufacturing supply chains. Efficient scale-up available for global agrochemical intermediate procurement strategies.
Novel Salen Co catalysis method reduces costs and improves supply chain reliability for high-purity rosuvastatin calcium intermediate manufacturing globally.
Discover a robust biocatalytic route for (2S, 3R)-methyl phenyl glycidate using Enterobacter sp. ECU 1107, offering superior purity and scalable manufacturing for taxol synthesis.
Patent CN115181282B reveals a template-free synthesis for double-layer hollow ring supramolecules, offering significant cost reduction in advanced materials manufacturing.
Novel ketoreductase method for ezetimibe intermediate. Reduces cost, improves purity. Reliable supplier for pharma intermediates.